Is ACUR or EQR a better dividend investment in 2026?

ACUR currently yields 20000.00% with a 5% 5-year dividend growth rate. EQR yields 4.73% with 5% growth. The better choice depends on your goal: ACUR offers higher current income.

What is the dividend yield difference between ACUR and EQR?

ACUR has a forward dividend yield of 20000.00% ($2.00/share annually). EQR yields 4.73% ($2.77/share annually). The yield gap is 19995.27 percentage points.

Home › Compare › ACUR vs EQR

ACUR vs EQR: Dividend Comparison 2026

ACUR yields 20000.00% · EQR yields 4.73%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ACUR wins by $52481917574412746752.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ACUR

● Live price

20000.00%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$52481917574412746752.00M

Annual income

$51,970,745,957,167,775,000,000,000.00

Full ACUR calculator →

EQR

● Live price

4.73%

Share price

$58.58

Annual div

$2.77

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40.5K

Annual income

$3,819.61

Full EQR calculator →

Portfolio growth — ACUR vs EQR

📍 ACUR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ACUR	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ACUR + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ACUR pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACUR

Annual income on $10K today (after 15% tax)

$1,700,000.00/yr

After 10yr DRIP, annual income (after tax)

$44,175,134,063,592,610,000,000,000.00/yr

EQR

Annual income on $10K today (after 15% tax)

$401.93/yr

After 10yr DRIP, annual income (after tax)

$3,246.67/yr

At 15% tax rate, ACUR beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACUR + EQR for your $10,000?

ACUR: 50%EQR: 50%

100% EQR50/50100% ACUR

Portfolio after 10yr

$26240958787206373376.00M

Annual income

$25,985,372,978,583,888,000,000,000.00/yr

Blended yield

99.03%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

ACUR

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-635.4

Piotroski

2/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+20.1% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACUR buys

EQR buys

No recent congressional trades found for ACUR or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricACUREQR

Forward yield	20000.00% ✓	4.73%
Annual dividend / share	$2.00	$2.77 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$52481917574412746752.00M ✓	$40.5K
Annual income after 10y	$51,970,745,957,167,775,000,000,000.00 ✓	$3,819.61
Total dividends collected	$52448189483771600896.00M ✓	$16.9K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold

Year-by-year: ACUR vs EQR ($10,000, DRIP)

Year	ACUR Portfolio	ACUR Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$2,010,700	$2,000,000.00	$11,248	$547.57	+$2.00M → ACUR
2	$377,983,225	$375,831,775.70	$12,701	$666.53	+$377.97M → ACUR
3	$66,433,479,469	$66,029,037,418.28	$14,405	$814.59	+$66433.47M → ACUR
4	$10,916,985,471,987	$10,845,901,648,955.73	$16,413	$999.84	+$10916985.46M → ACUR
5	$1,677,384,363,769,318	$1,665,703,189,314,291.80	$18,795	$1,232.92	+$1677384363.75M → ACUR
6	$240,985,175,079,139,100	$239,190,373,809,905,920.00	$21,639	$1,527.95	+$240985175079.12M → ACUR
7	$32,373,573,631,143,694,000	$32,115,719,493,809,017,000.00	$25,057	$1,903.80	+$32373573631143.67M → ACUR
8	$4,066,766,648,320,630,000,000	$4,032,126,924,535,306,000,000.00	$29,197	$2,385.87	+$4066766648320630.00M → ACUR
9	$477,730,483,406,513,300,000,000	$473,379,043,092,810,300,000,000.00	$34,250	$3,008.70	+$477730483406513344.00M → ACUR
10	$52,481,917,574,412,750,000,000,000	$51,970,745,957,167,775,000,000,000.00	$40,467	$3,819.61	+$52481917574412746752.00M → ACUR

ACUR vs EQR: Complete Analysis 2026

ACUR — Stock

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois.

Full ACUR Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this ACUR vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACUR vs SCHD ACUR vs JEPI ACUR vs O ACUR vs KO ACUR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.